|
|
|
|
|
by llamaimperative
638 days ago
|
|
Clinical trials in general are extremely, extremely above board. The level of scrutiny is extreme, and the stakes are unbelievably high for pharma companies and the individuals involved. There are better ways for an unscrupulous pharma co to gain an edge. That said, wonder drugs are few and far between. The GLPs are at least a once-in-a-decade breakthrough, so that’s probably most of the noise you’re hearing (there are a lot of brand names already). |
|